[{"address1": "One Research Court", "address2": "Suite 450", "city": "Rockville", "state": "MD", "zip": "20850", "country": "United States", "phone": "240 403 4212", "website": "https://www.shuttlepharma.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas, SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers. The company was founded in 2012 and is based in Rockville, Maryland.", "fullTimeEmployees": 7, "companyOfficers": [{"maxAge": 1, "name": "Dr. Anatoly  Dritschilo M.D.", "age": 79, "title": "Co-Founder, MD, CEO & Chairman of the Board", "yearBorn": 1944, "fiscalYear": 2022, "totalPay": 91418, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter Dale Dritschilo M.B.A., M.D.", "age": 54, "title": "President & COO", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": 94289, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael P. Vander Hoek", "age": 63, "title": "CFO and VP of Operations & Regulatory", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 79480, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tyvin A. Rich M.D.", "age": 75, "title": "Chief Medical Officer", "yearBorn": 1948, "fiscalYear": 2022, "totalPay": 65065, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Milton  Brown CSC, M.D., Ph.D.", "age": 58, "title": "Co-Founder & Director", "yearBorn": 1965, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mira  Jung Ph.D.", "age": 74, "title": "Co-Founder & Chief Scientific Officer for Biology", "yearBorn": 1949, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gene  Jung Esq.", "title": "General Counsel", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.41, "open": 0.4, "dayLow": 0.4, "dayHigh": 0.4239, "regularMarketPreviousClose": 0.41, "regularMarketOpen": 0.4, "regularMarketDayLow": 0.4, "regularMarketDayHigh": 0.4239, "volume": 38069, "regularMarketVolume": 38069, "averageVolume": 168738, "averageVolume10days": 50790, "averageDailyVolume10Day": 50790, "bidSize": 1400, "askSize": 1200, "marketCap": 6723395, "fiftyTwoWeekLow": 0.35, "fiftyTwoWeekHigh": 2.75, "fiftyDayAverage": 0.42002, "twoHundredDayAverage": 0.669535, "currency": "USD", "enterpriseValue": 854110, "floatShares": 8781120, "sharesOutstanding": 16069300, "sharesShort": 87690, "sharesShortPriorMonth": 83998, "sharesShortPreviousMonthDate": 1705017600, "dateShortInterest": 1707955200, "sharesPercentSharesOut": 0.0055, "heldPercentInsiders": 0.45821998, "heldPercentInstitutions": 0.022160001, "shortRatio": 0.39, "shortPercentOfFloat": 0.0091, "bookValue": 0.351, "priceToBook": 1.1920227, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -5703132, "trailingEps": -0.4, "enterpriseToEbitda": -0.16, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "SHPH", "underlyingSymbol": "SHPH", "shortName": "Shuttle Pharmaceuticals Holding", "longName": "Shuttle Pharmaceuticals Holdings, Inc.", "firstTradeDateEpochUtc": 1661952600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "7d533843-75d5-319f-b923-9ea3e624e2b7", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.4184, "recommendationKey": "none", "totalCash": 6806589, "totalCashPerShare": 0.425, "ebitda": -5344030, "totalDebt": 966666, "quickRatio": 8.414, "currentRatio": 8.632, "debtToEquity": 17.232, "returnOnAssets": -0.39909, "returnOnEquity": -0.81388, "freeCashflow": -2738923, "operatingCashflow": -5198840, "financialCurrency": "USD", "trailingPegRatio": null}]